Events

This webinar explores the scope of the new USG Policy for High-Risk Life Sciences Research.

This workshop features updates from the FDA on establishment registration and drug listing submissions.

Review how the NIH Policy on Enhancing Security Measures for Human Biospecimens tightens controls on sensitive personal data.

Teaches how behavioral science can enhance compliance programs by exploring human decision-making drivers.

Discusses that IRB exemptions are underutilized because many institutions take a very conservative approach when applying them.

Explores the seven key elements that ensure regulatory adherence, mitigate administrative risks, and promote ethical research administration.

Serves as an introduction to open science principles and practices.

Join the NIH for the "Clinical Center Ethics Grand Rounds: Ethics Of Reducing the Use of Animals In Research" session on October 7, 2026.

Discuss toxicological risk assessments used to address biocompatibility endpoints for medical devices.

Join the NIH for the "Beyond the Lab: Insights into Clinical Development in Pharma" workshop on October 7, 2026.

This event focuses on the FDA's January 2026 draft guidance, "Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products."

Join the NIH for the "From Postdoc to CEO" workshop, presented by Andrew Sinkoe, Founder and CEO of Sesh Incorporated.

Join the NIH for its upcoming webinar, "Extending Human Healthspan: Considering Psychosocial Drivers of Healthy Aging."

The NIST is hosting a quarterly call to address the cybersecurity needs of the small business community.

The U.S. Food and Drug Administration (FDA) will host a hybrid meeting of the Microbiology Devices Panel of the Medical Devices Advisory Committee.

The FDA will host a hybrid, two-day public workshop focused on autonomous and remote teleoperated robotic medical devices.